AbsTech

AbsTech is at the forefront of biotechnology research, dedicated to revolutionizing chemotherapy delivery and improving patient outcomes. With a focus on decreasing patient harm and increasing the therapeutic success of chemotherapies, AbsTech is developing a next-generation drug delivery platform that surpasses current solutions. This innovative platform is designed to enable more effective and safer treatments for patients with solid tumors.

Located primarily in Montréal & Sherbrook, Quebec, AbsTech's proprietary delivery system aims to reduce chemotherapy toxicity significantly, potentially improving patient quality of life. The platform is engineered for faster and more cost-effective development and is applicable to a broad range of solid tumor treatments. AbsTech offers strategic opportunities for pharmaceutical companies looking to enhance the therapeutic index of their existing therapies, fostering strong partnerships and collaborative growth.

AbsTech is committed to advancing oncology through cutting-edge drug delivery solutions. The company’s advancements promise to enhance the efficacy and safety of chemotherapy treatments. We invite the manager of AbsTech to create a customized and exclusive company showcase and product listing on our platform, further highlighting their contributions to the biotechnology field.